FIGUR8 – a leading innovator in the measure of musculoskeletal (MSK) health, has successfully closed a $25 million Series A-1 funding. The funding round was led by First Spark Ventures (FSV) with participation from DigiTx Partners and Phoenix Venture Partners.
FIGUR8 plans use the proceeds to drive growth and adoption of its core bioMotion Assessment Platform (bMAP). By utilizing lab-grade biomechanics data captured in the clinic setting, valuable insights into musculoskeletal health and injury recovery can lead to more personalized and data-driven recovery pathways.
FIGUR8’s bMAP produces accurate, precise, and objective data for musculoskeletal care and injury recovery. And FIGUR8’s advanced data empowers providers to better communicate symptoms, diagnosis and progress, while enabling payers to improve claims and underwriting processes, optimize risk management strategies, and promote faster recovery among injured workers.
Manish Kothari, PhD and Dr. Christina Jenkins will join FIGUR8’s board of directors.
KEY QUOTES:
“We are thrilled to have FSV leading this important investment round. FSV’s experience in backing transformative technologies and strategic guidance will not only bolster our efforts to elevate the musculoskeletal industry, but also pave the way for significant advancements in digital MSK health, as FIGUR8 elevates the standard of care with codified, clinically-relevant data.”
— Nan-Wei Gong, founder and CEO of FIGUR8
“Mobility is an essential part of who we are and how we function. FIGUR8 brings a proven, deeply scientific way to guide the best pathways for restoration of mobility. Objective MSK data enables a new level of personalized healthcare and risk evaluation, while simultaneously reducing cost and strongly improving satisfaction across patients, providers and payers.”
— Manish Kothari, Founding Managing Partner of First Spark Ventures
“As a physician and staunch advocate of evidence-backed solutions, I am thrilled to serve on FIGUR8’s board. FIGUR8’s unique approach to biometric sensing technology removes some of the ‘art’ of diagnosis and assessment, transforming MSK care into a standardized and data-driven science that empowers patients and providers to improve health. The company’s model is rare, aligning incentives across payer, provider and patient, and helping to pave the way for adoption and the evolution of the standard of care. We’re excited for FIGUR8’s opportunity to set a new industry benchmark.”
— Dr. Christina Jenkins of Phoenix Venture Partners
